This Article Abstract Full Text Full Text (PDF) Online Appendix View Related Cardiosource Journal Scan Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Brodie, B. R. Search for Related Content PubMed Articles by Brodie, B. R. Related Collections Related Article

Outcomes With Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Graft Intervention

Results From the STENT (Strategic Transcatheter Evaluation of New Therapies) Group

Bruce R. Brodie, MD^_*,_*, Hadley Wilson, MD, Thomas Stuckey, MD^_*, Marcy Nussbaum, Sherry Laurent, Barbara Bradshaw, RN^_*, Angela Humphrey, Chris Metzger, MD, James Hermiller, MD^||, Fred Krainin, MD^¶, Stanley Juk, MD^#, Barry Cheek, MD^_**, Peter Duffy, MD, Charles A. Simonton, MD for the STENT Group

^_* The LeBauer Cardiovascular Research Foundation, Greensboro, North Carolina
Carolinas Medical Center, Charlotte, North Carolina
R. Stuart Dickson Institute for Health Studies, Charlotte, North Carolina
Holston Valley Medical Center, Kingsport, Tennessee
^|| Indiana Heart Institute, Indianapolis, Indiana
^¶ McLeod Regional Medical Center, Florence, South Carolina
^# Sisters of Charity Providence Hospitals, Columbia, South Carolina
^_** High Point Regional Health System, High Point, North Carolina
Moore Regional Medical Center, Pinehurst, North Carolina

View larger version (16K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Our Study Population Consisting of All Patients With SVG Intervention Who Were Treated With DES Only or BMS Only and Who Completed 9-Month or 2-Year Follow-Up BMS = bare-metal stent(s); DES = drug-eluting stent(s); f/u = follow-up; PCI = percutaneous coronary intervention; SVG = saphenous vein graft.

View larger version (11K): [in this window] [in a new window] [Download PPT slide]   Figure 2 Kaplan-Meier Estimates of Event Rates for Death or MI in Patients Undergoing SVG Intervention With DES Versus BMS HR = hazard ratio; MI = myocardial infarction; other abbreviations as in Figure 1.

View larger version (12K): [in this window] [in a new window] [Download PPT slide]   Figure 3 Kaplan-Meier Estimates of Event Rates for TVR in Patients Undergoing SVG Intervention With DES Versus BMS TVR = target vessel revascularization; other abbreviations as in Figures 1 and 2.

View larger version (9K): [in this window] [in a new window] [Download PPT slide]   Figure 4 Kaplan-Meier Estimates of Event Rates for Stent Thrombosis in Patients Undergoing SVG Intervention With DES Versus BMS Abbreviations as in Figures 1 and 2.